Genmab — Juni 2022
-
JnJ om darzalex: it’s gonna be our largest drug https://twitter.com/bertrandbio/status/1532009827899260931?s=21&t=189vAgnCO369-t3SHoVu8g
-
Major Shareholder Announcement Wellington Management Group LLP has informed us that, as of May 27, 2022, Wellington Management Group LLP through shares and financial instruments holds the voting rights 5.01% of the share capital and voting rights in Genmab A/S. https://www.globenewswire.com/news-release/2022/06/01/2454605/0/en/Major-Shareholder-Announcement.html
-
Johnson & Johnson (JNJ) CEO Joaquin Duato Presents at Bernstein 38th Annual Strategic Decisions Conference https://seekingalpha.com/article/4515795-johnson-and-johnson-jnj-ceo-joaquin-duato-presents-bernstein-38th-annual-strategic-decisions
-
Tx, It's super exciting to look at what we are doing in multiple myeloma now. When you think about the 97% response rates with cell therapy, and you think about the potential of combining cell therapy with DARZALEX and with our bispecific antibody and sequence these therapies, you could think about the day in which this incurable disease could become chronically managed.
-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind